相似文献
1
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated Individuals.
Clin Infect Dis. 2022 Aug 24;75(1):e869-e873. doi: 10.1093/cid/ciac201.
2
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
Clin Infect Dis. 2023 Feb 8;76(3):e439-e449. doi: 10.1093/cid/ciac392.
3
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.
Am J Kidney Dis. 2021 Oct;78(4):571-581. doi: 10.1053/j.ajkd.2021.06.002. Epub 2021 Jun 24.
4
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
5
Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers.
Int J Infect Dis. 2022 Oct;123:183-191. doi: 10.1016/j.ijid.2022.08.022. Epub 2022 Aug 28.
6
Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies.
Rev Med Virol. 2022 Mar;32(2):e2277. doi: 10.1002/rmv.2277. Epub 2021 Jul 19.
7
SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2215677. doi: 10.1080/21645515.2023.2215677. Epub 2023 Jun 1.
8
Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients.
Front Immunol. 2022 Apr 22;13:869990. doi: 10.3389/fimmu.2022.869990. eCollection 2022.
9
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
10
Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay.
Microbiol Spectr. 2021 Dec 22;9(3):e0120221. doi: 10.1128/Spectrum.01202-21. Epub 2021 Nov 24.
引用本文的文献
1
Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults.
Vaccines (Basel). 2023 Nov 11;11(11):1711. doi: 10.3390/vaccines11111711.
2
Influence of the Single Nucleotide Polymorphisms rs12252 and rs34481144 in on the Antibody Response after Vaccination against COVID-19.
Vaccines (Basel). 2023 Jul 19;11(7):1257. doi: 10.3390/vaccines11071257.
3
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review.
Infect Dis Ther. 2023 Feb;12(2):367-387. doi: 10.1007/s40121-022-00753-2. Epub 2023 Jan 9.
4
c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine.
Front Genet. 2022 Aug 29;13:932043. doi: 10.3389/fgene.2022.932043. eCollection 2022.
5
Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines.
Biomedicines. 2022 Jul 12;10(7):1676. doi: 10.3390/biomedicines10071676.
本文引用的文献
1
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6.
2
BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype.
Sci Immunol. 2021 Dec 24;6(66):eabl5344. doi: 10.1126/sciimmunol.abl5344.
3
mRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant.
Clin Infect Dis. 2022 Aug 24;75(1):e898-e901. doi: 10.1093/cid/ciab915.
4
Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.
N Engl J Med. 2021 Nov 18;385(21):2010-2012. doi: 10.1056/NEJMc2115596. Epub 2021 Oct 15.
5
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
Science. 2021 Dec 3;374(6572):abm0829. doi: 10.1126/science.abm0829.
6
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
J Virol. 2021 Nov 9;95(23):e0131321. doi: 10.1128/JVI.01313-21. Epub 2021 Sep 22.
7
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273.
Clin Microbiol Infect. 2022 May;28(5):701-709. doi: 10.1016/j.cmi.2021.09.006. Epub 2021 Sep 20.
8
Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals.
Cell Rep Med. 2021 Jul 20;2(7):100355. doi: 10.1016/j.xcrm.2021.100355. Epub 2021 Jul 2.
9
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Jul 22;385(4):320-329. doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30.
10
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.
Sci Immunol. 2021 May 25;6(59). doi: 10.1126/sciimmunol.abj1750.
Zotero 插件